Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy of crenolanib and apoptosis pathway agents for the treatment of proliferative disorders

Combination therapy of crenolanib and apoptosis pathway agents for the treatment of proliferative disorders

US Patent 11969420 · Granted Apr 30, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystal forms of crenolanib and methods of use thereof2025
Crenolanib for treating FLT3 mutated proliferative disorders associated mutation2025
Combination therapy of crenolanib and apoptosis pathway agents for the treatment2025
Methods and systems for screening and design of corrosion inhibitors2025
Crenolanib for treating FLT3 mutated proliferative disorders relapsed/refractory2025
Edge device implanting a logical network that spans across multiple routing tabl2025
Process for preparing filled hard-shell capsules with cellulose or starch-based 2025
Crenolanib for treating FLT3 mutated proliferative disorders2024
Process for preparing a coated hard shell capsule2024
Crenolanib for treating FLT3 mutated proliferative disorders relapsed/refractory2024
Method of inhibiting constitutively active phosphorylated FLT3 kinase2023
Edge device implementing a logical network that spans across multiple routing ta2023